Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 211-220 of 730 results
Journal of Neuroinflammation, 2016 • April 14, 2016
The study investigates the role of APRIL in fibrotic scar formation after SCI, finding that APRIL and BCMA expression increases following SCI. Genetic deletion of APRIL resulted in reduced fibrotic sc...
KEY FINDING: APRIL expression, along with its receptor BCMA, increases following spinal cord injury.
Neural Regen Res, 2023 • July 1, 2023
This review summarizes the important metabolic pathways involved in SCI as well as the importance of enolase activity on the cell surface following SCI. Interaction at the cell surface allows enolase ...
KEY FINDING: Enolase promotes both pro- and anti-inflammatory events and regulates functional recovery in SCI.
Neural Regeneration Research, 2023 • September 1, 2023
The review focuses on the role of matrix metalloproteases (MMPs) in spinal cord injury (SCI) and the potential of MMP inhibitors as a therapeutic strategy. MMPs contribute to several detrimental proce...
KEY FINDING: MMP-9 and MMP-2 are upregulated after SCI, contributing to BSCB breakdown, inflammation, and apoptosis.
Journal of Neuroinflammation, 2021 • June 9, 2021
The study demonstrates that S100A4 is upregulated in fibroblasts from ALS patients and in the spinal cord of hFUS mice, suggesting it is a common pathological trait of ALS. Silencing S100A4 in ALS fib...
KEY FINDING: S100A4 is upregulated in fibroblasts from ALS patients, regardless of the specific gene mutation, suggesting it is a common pathological trait.
Journal of Neuroinflammation, 2021 • January 1, 2021
This study identifies D-DT as a novel inflammatory activator of astrocytes following spinal cord injury, suggesting it could be a beneficial target for anti-inflammation drug development in neuropatho...
KEY FINDING: D-DT expression is induced in astrocytes and neurons, but not microglia, following spinal cord contusion, indicating a cell-specific response to injury.
Journal of Neuroinflammation, 2023 • October 26, 2023
The study investigates the neuroendocrine mechanisms underlying SCI-induced immunodeficiency syndrome (SCI-IDS) using multitissue transcriptomic analysis in rats with high-level (T3) and low-level (T1...
KEY FINDING: High-level SCI leads to significant atrophy of immune organs like the thymus and spleen, while low-level SCI shows gradual recovery of these organs.
Journal of Neuroinflammation, 2021 • May 7, 2021
The study aimed to elucidate the system-wide changes induced by minocycline treatment in a rodent model of cervical SCI, focusing on the microbiota-immune axis and behavioral outcomes. Minocycline tre...
KEY FINDING: Minocycline had a profound acute effect on the microbiota diversity and composition, which was paralleled by the subsequent normalization of spinal cord injury-induced suppression of cytokines/chemokines.
J Neurochem, 2016 • September 1, 2016
Neuroinflammation plays a critical role in neurodegenerative diseases, making innate immune activation a promising therapeutic target. This mini review series originated from the 4th Venusberg Meeting...
KEY FINDING: Microglia, the brain's immune cells, have diverse morphologies and functions depending on their environment and stage of development.
Eur Spine J, 2007 • November 14, 2006
The study presents a rare case of cervical intramedullary brucellar granuloma (IBG) in a 35-year-old female, who had a history of Brucella meningitis and improper medication intake. The patient presen...
KEY FINDING: This case represents the first reported instance of intramedullary granuloma of the cervical spine caused by Brucella. Prior cases involved the thoracic spine or conus medullaris.
BMC Pulmonary Medicine, 2024 • October 7, 2024
This study investigated the relationship between plasma fibrinogen levels and the incidence of pulmonary infection (PI) in patients with spinal cord injury (SCI). The study found that elevated plasma ...
KEY FINDING: For every 1 g/L increase in fibrinogen level, the risk of developing PI increased by 18% (HR = 1.18, P = 0.011), and indicating a positive linear relationship between fibrinogen level and PI incidence.